Zimmer Biomet Holdings Inc (ZBH)
108.19
-0.03
(-0.03%)
USD |
NYSE |
Jun 26, 11:04
Zimmer Biomet Holdings Research and Development Expense (Annual): 458.70M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 458.70M |
| December 31, 2022 | 406.00M |
| December 31, 2021 | 435.80M |
| December 31, 2020 | 322.80M |
| December 31, 2019 | 449.30M |
| December 31, 2018 | 391.70M |
| December 31, 2017 | 369.90M |
| December 31, 2016 | 365.60M |
| December 31, 2015 | 268.80M |
| December 31, 2014 | 191.90M |
| December 31, 2013 | 203.80M |
| December 31, 2012 | 225.60M |
| Date | Value |
|---|---|
| December 31, 2011 | 238.40M |
| December 31, 2010 | 218.50M |
| December 31, 2009 | 205.70M |
| December 31, 2008 | 192.30M |
| December 31, 2007 | 209.60M |
| December 31, 2006 | 188.30M |
| December 31, 2005 | 175.50M |
| December 31, 2004 | 166.70M |
| December 31, 2003 | 105.80M |
| December 31, 2002 | 80.70M |
| December 31, 2001 | 71.60M |
| December 31, 2000 | 52.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
322.80M
Minimum
2020
458.70M
Maximum
2023
414.52M
Average
435.80M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Stryker Corp | 1.388B |
| ResMed Inc | 287.64M |
| Align Technology Inc | 346.83M |
| ThermoGenesis Holdings Inc | 1.284M |
| Nutriband Inc | 1.960M |